Weight loss drugs are so hot that Eli Lilly is expecting $2 billion more in sales this year
0
Eli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its weight loss drug Zepbound in the first quarter of 2024.